首页> Leukemia research> The presence of clonal isotype switch after autologous stem cell transplantation as a prognostic biomarker for long-term survival in patients with multiple myeloma.

The presence of clonal isotype switch after autologous stem cell transplantation as a prognostic biomarker for long-term survival in patients with multiple myeloma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Hanwool,Cho

第一单位： Department of Laboratory Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.

作者： Hanwool,Cho ^[1] ; Jinhang,Kim ^[2] ; Youngrok,Park ^[3] ; Bo-Hee,Lee ^[4] ; Misuk,Yang ^[2] ; Yeongsic,Kim ^[1] ; Jeong-A,Kim ^[5]

作者单位： Department of Laboratory Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea. ^[1] Division of Hematology, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea. ^[2] Tumor Biology Training Program, Lombardi Comprehensive Cancer Center, Georgetown University School of Medicine, Washington, DC, United States. ^[3] Department of Hemato-Oncology, G-SAM Hospital, Gunpo, South Korea. ^[4] Division of Hematology, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea. Electronic address: jakim@catholic.ac.kr. ^[5]

关键词 Autologous stem cell transplantation Clonal isotype switch Multiple myeloma